Atlas Trials

Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

Clinical trial NCT01418339 · COMPLETED

Trial details

NCT number
NCT01418339
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Tourette's Disorder
Start date
2011-07-27
Primary completion
2013-11-06
Enrollment
135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.